Disease-modifying effect and economic implications of sublingual immunotherapy

被引：25

作者：

Canonica, Giorgio Walter ^{[1
]}

Passalacqua, Giovanni ^{[1
]}

机构：

[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 01期

关键词：

Sublingual immunotherapy; respiratory allergy; preventive effect; pharmacoeconomy; POLLEN-INDUCED RHINOCONJUNCTIVITIS; COST-EFFECTIVENESS; ASTHMA; ALLERGY; CHILDREN; PREVENTION; GRAZAX(R); EFFICACY; RHINITIS; UPDATE;

D O I：

10.1016/j.jaci.2010.09.037

中图分类号：

R392 [医学免疫学];

学科分类号：

100108 [医学免疫学];

摘要：

引用

页码：44 / 45

页数：2

共 20 条

[1]

Cost-effectiveness of grass allergen tablet (GRAZAX®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis -: a Northern European perspective [J].

Bachert, C. ;

Vestenbaek, U. ;

Christensen, J. ;

Griffiths, U. K. ;

Poulsen, P. B. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (05) :772-779

[2]

Berto P, 2005, Eur Ann Allergy Clin Immunol, V37, P303

[3]

Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study [J].

Berto, Patrizia ;

Frati, Franco ;

Incorvaia, Cristoforo ;

Cadario, Gianni ;

Contiguglia, Rosario ;

Di Gioacchino, Mario ;

Puccinelli, Paola ;

Senna, Gian Enrico ;

Valle, Carla .

CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) :261-266

[4]

Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study [J].

Berto, Patrizia ;

Passalacqua, Giovanni ;

Crimi, Nunzio ;

Frati, Franco ;

Ortolani, Claudio ;

Senna, Gianenrico ;

Canonica, Giorgio Walter .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (05) :615-621

[5]

Economic studies of immunotherapy: a review [J].

Berto, Patrizia ;

Frati, Franco ;

Incorvaia, Cristoforo .

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 8 (06) :585-589

[6]

Immunotherapy: clinical trials - optimal trial and clinical outcomes [J].

Bousquet, Philippe Jean ;

Demoly, Pascal ;

Passalacqua, Giovanni ;

Canonica, G. Walter ;

Bousquet, Jean .

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 7 (06) :561-566

[7]

Grading quality of evidence and strength of recommendations in clinical practice guidelines [J].

Brozek, J. L. ;

Akl, E. A. ;

Alonso-Coello, P. ;

Lang, D. ;

Jaeschke, R. ;

Williams, J. W. ;

Phillips, B. ;

Lelgemann, M. ;

Lethaby, A. ;

Bousquet, J. ;

Guyatt, G. H. ;

Schuenemann, H. J. .

ALLERGY, 2009, 64 (05) :669-677

[8]

Cost-effectiveness of GRAZAX® for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe [J].

Canonica, G. W. ;

Poulsen, P. B. ;

Vestenbaek, U. .

RESPIRATORY MEDICINE, 2007, 101 (09) :1885-1894

[9]

Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x

[10]

Recommendations for appropriate sublingual immunotherapy clinical trials [J].

Casale, Thomas B. ;

Canonica, G. Walter ;

Bousquet, Jean ;

Cox, Linda ;

Lockey, Richard ;

Nelson, Harold S. ;

Passalacqua, Giovanni .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (04) :665-670

← 1 2 →